P

Inventor

LAPORTE MATTHEW G

US34 patents
⚠️ This page may combine multiple inventors who share the name “LAPORTE MATTHEW G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TETRALOGIC PHARM CORP

9 patents

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

9 patents
US11214560B2Jan 4, 2022

Modulators of P97 AAA ATPase activity

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION3 citations73
US11773075B2Oct 3, 2023

Modulators of p97 AAA ATPase activity

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations62
US10894782B2Jan 19, 2021

Modulators of P97 AAA ATPase activity

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION1 citations62
US11111253B2Sep 7, 2021

6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations59
US12559480B2Feb 24, 2026

Methods of treatment using phenyl indole allosteric inhibitors of P97 ATPase

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations56
US11247985B2Feb 15, 2022

Phenyl indole allosteric inhibitors of P97 ATPase

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations56
US12486231B2Dec 2, 2025

Targeted nitroxide compounds and their use in treating ferroptosis-related diseases

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations52
US10618914B2Apr 14, 2020

6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-B][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations49
US10633370B2Apr 28, 2020

Phenyl indole allosteric inhibitors of p97 ATPase

UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations46

CONDON STEPHEN M

7 patents

TETRALOGIC BIRINAPANT UK LTD

4 patents

MEDIVIR AB

3 patents

TETRALOGIC PHARMACEUTICALS COR

1 patent

VIROPHARMA INC

1 patent